Vantis Vascular

Funding and NIH signals

• SEC Form D raise Raised $18.64M (Form D filed Jul 10, 2026). SEC Form D 0002080612-26-000043 (Jul 10, 2026)
  Evidence (1 event)

  • Jul 10, 2026 · SEC Form D 0002080612-26-000043
    Name of Issuer: Vantis Vascular, Inc.; CIK: 1761882; Address: San Jose, CA; Submission type: D; Filing date: 2026-07-10; Industry Group: Other; Date of First Sale: 2026-06-26; Types of Securities Offered: Equity, Option/warrant, Security to be acquired; Business combination transaction: false; Total Offering Amount: 21500000; Total Amount Sold: 18639500; Federal exemptions: 06b
• NIH award NIH awarded $496K (SBIR commercialization 1SB1HL184525-01, new, notice Sep 1, 2026); 2 NIH awards totaling $1.49M in the last 12 months. NIH RePORTER 1SB1HL184525-01 (Sep 1, 2026)
  Evidence (2 events)

  • Sep 1, 2026 · NIH RePORTER 1SB1HL184525-01
    Organization: VANTIS VASCULAR INC; City/State: KALAMAZOO, MI; Project number: 1SB1HL184525-01; Activity code: SB1; Fiscal year: 2026; Award notice date: 2026-09-01; FY total cost (award amount): 496437; Administering IC: National Heart Lung and Blood Institute; Project title: Commercial Readiness of a Catheter for Complex Percutaneous Coronary Intervention; Organization type: Domestic For-Profits
  • Aug 25, 2026 · NIH RePORTER 5R44HL152835-06
    Organization: VANTIS VASCULAR INC; City/State: KALAMAZOO, MI; Project number: 5R44HL152835-06; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-25; FY total cost (award amount): 997212; Administering IC: National Heart Lung and Blood Institute; Project title: Catheter for Complex Percutaneous Coronary Intervention; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals